Frequently Asked Questions : About Postpartum Depression
Research
| About Postpartum Depression
What are the baby blues?
What is postpartum depression?
Who is at risk for postpartum depression?
How can I be screened for postpartum depression?
What happens when depression is left untreated?
What are possible treatments for postpartum depression?
Won’t the antidepressant medication harm my baby?
Can women breast-feed and take anti-depressants at the same time?
If the antidepressent is supposed to
help my sleep disturbance and “knocks me out”, will I sleep through
my baby’s cry?
The depressive symptoms are no longer
present. Can I stop taking my antidepressant medication?
If I tell someone about my thoughts or symptoms,
won’t I be at risk for losing my baby?
What is postpartum psychosis?

Q. What are the baby blues?
A. The baby blues affect up to 75% of mothers
shortly after the delivery. The symptoms may include brief crying
spells, bouts of irritability, nervousness, strong feelings of
sadness or joy, headache, poor sleep, changes in eating habits,
making difficult decisions, and more intense emotional reactions.
The baby blues usually start 2-4 days after birth, and go away
within a few days or by 10 days after birth. No treatment is
necessary.

Q. What is postpartum depression?
A. Postpartum depression is a common illness. Women
such as Princess Diana and Marie Osmond have experienced postpartum
depression. It occurs in 10-15% (1 out of 8) new mothers. It tends
to begin within 4 weeks after delivery but may occur up to several
months after the baby is born. The symptoms of postpartum depression
must be present most of the day nearly every day for 2 continuous
weeks and include five of the symptoms listed below, one of which
must be either low or depressed mood OR loss of interest or
pleasure:
• Low or depressed mood
• Loss of interest or pleasure in activities
• Appetite changes- more often loss of appetite; others may notice
an increased appetite
• Sleep disturbance-usually insomnia or disrupted sleep, even when
the baby sleeps; others may have increased sleep
• Poor energy
• Excessive guilt
• Feelings of worthlessness
• Poor concentration or difficulty making decisions
• Agitation or feelings of being slowed down
More severe symptoms could include thoughts of death or suicidal
thoughts. Women may also experience increased anxiety or worrying,
obsessional thoughts (repeated, unwanted or intrusive thoughts that
are hard to ignore), and panic attacks.
Depression results when the stress from the environment is greater
than the capacity of the person to cope. Any one can develop
depression. There are many treatments.

Q. Who is at risk for postpartum depression?
A. Like most diseases, there is not one factor responsible
for the development of depression. Women most likely to suffer the
onset of a new episode of depression have a history of depression,
significant life stressors, a negativistic style of thinking, and
less social support than women who do not develop episodes. Research
is being undertaken to explore the connection between the major
drop in hormone levels shortly after delivery, which causes major
physiological stress, and postpartum
depression.

Q. How can I be screened for postpartum depression?
A. Women can complete a self-rating questionnaire
called the Edinburgh Postnatal Depression Scale to determine if
they might have postpartum depression. Please fill
out the questionnaire.
If your score is 10 or above, or if you have had recent thoughts
of harming yourself, your baby, or anyone else, it is important
for you to see your primary care provider or your mental health
provider in the near future for a clinical assessment.
If your score is between 5-9, then you may wish to repeat this questionnaire
in 2-4 weeks to determine if your symptoms have changed. Please
call us or see your physician for any questions.

Q. What happens when depression is left untreated?
A. Women can remain untreated because they don't
realize they have depression, or because they have been discouraged
from getting treatment. But women with postpartum depression are
not alone! At one out of eight women, this is the most common complication
of childbearing. Without treatment, depression usually lasts 6-9
months. Women with untreated postpartum depression can experience
ongoing difficulties with work and relationships. They may have
problems taking care of things at home, getting along with others,
doing their jobs, or doing things that used to be done easily. Other
mothers have described a difficulty being able to enjoy their new
baby, fears of harming their infant or not being able to meet the
needs of their child/children.

Q. What are possible treatments for postpartum
depression?
A. Treatments for postpartum depression are
designed to address the woman’s management of the stress that she
experiences. Stress can come from outside the person (such as an ill
parent or child, or financial problems) or from inside (such as a
chronic medical illness or a hereditary vulnerability to
depression). Psychotherapy and/or antidepressant medications are
established treatments. Cognitive behavior therapy and interpersonal
therapy have been found helpful in treating this condition. These
treatments encourage the woman to evaluate her situation and change
the situations over which she has control. Antidepressant
medications include the serotonin-selective reuptake inhibitors such
as fluoxetine (prozac) and sertraline (zoloft), venlafaxine (effexor),
which is a norepinephrine and serotonin reuptake inhibitor, and the
tricyclic agents, an older class of antidepressants. Medications
take a few weeks to work. They correct the core symptoms of
dysregulation of depression. Other promising treatments are being
evaluated in clinical trials (some right here in Pittsburgh, which
has the largest research Center in the country at UPMC). Bright
light therapy is a treatment that restores biological rhythms (such
as sleep and appetite problems) to normal by exposing the woman to
bright light in the morning with a special light box. Acupuncture is
another promising therapy. The role of estrogen as a treatment is
being explored. We recommend that women consider these therapies and
select those that are most consistent with their own values.
Treatment studies are
available at the WBHC.
Since women who have had one prior episode of postpartum
depression have a 25% risk for another postpartum episode, it is
important that they be monitored more closely and seek treatment
immediately if symptoms occur, or that they be treated preventively
before the episode begins.

Q. Won’t the antidepressant medication harm my
baby? Can women breast-feed and take anti-depressants
at the same time?
A. There are a number of benefits to
breastfeeding. Many new mothers committed to breastfeeding their
newborns struggle with their concern that the antidepressant
medication, taken to alleviate the mother’s depression, may harm
their baby. The decision to bottle feed the baby means that the
benefits of breastfeeding will not be available to the baby.
Breastfeeding while depressed means that the baby will be exposed to
maternal depression. Women and health care practitioners must have
information to help with this decision making.
The benefits and risks of breastfeeding while taking medications
must be carefully considered and discussed with the physician. All
medications are excreted in breast milk. Our group and other
investigators have done research specifically focused on
antidepressant levels in breastfed full-term healthy infants of
mothers on antidepressant medications. Premature or ill newborns in
fact, may have greater difficulty metabolizing (breaking down) drugs
and may be at greater risk to having higher levels of antidepressant
medication.
In a comparison study, data on blood samples taken from 337
mothers and 238 infants were reviewed, including drug levels for 15
antidepressants. Antidepressants identified that did not develop
detectable or elevated blood levels in the breastfeeding infant
included: nortiptyline, paroxetine or sertraline. However, lack of
any measurable amount of antidepressant in the infant may not always
predict the long term effects of the medication on the infant. One
small study of infants (up to 30 months) exposed to the breast milk
of mothers on tricyclic antidepressants found no developmental
problems. The long term effects of infants exposed to serotonin
reuptake inhibitors in the breast milk are still not known.
It is most ideal to choose the lowest effective antidepressant dose
for lactating mothers and to carefully observe the breastfed infant
before and during the mother’s treatment on antidepressant
medication.

Q. If the antidepressent is supposed to
help my sleep disturbance and “knocks me out”, will I sleep through
my baby’s cry?
A. The antidepressant medication will help improve
the mother’s disturbed sleep patterns but will not be over-sedating
that the woman cannot wake and respond to her infant’s needs.
Antidepressants are not sedatives, but medications that correct the
dysregulation symptoms of this mood disorder as well as the symptom
of depression itself. They are not addicting.

Q. The depressive symptoms are no longer
present. Can I stop taking my antidepressant medication?
A. Often, women may treat their antidepressant
medication as they would a decongestant or pain reliever. The
symptoms are no longer present; the medication is no longer needed.
However, with antidepressant medication, symptoms reduce and resolve
when the medication is actively working. If the medication is
stopped, the symptoms may return. Another possible complication is
that the woman may experience uncomfortable physical withdrawal
symptoms if she stops the medication abruptly. These symptoms are
not because the medication is addicting (like alcohol or heroin),
but because sudden stopping of any drug that has multiple effects on
the body means that the body must readjust. These symptoms feel like
mild flu and are not life-threatening.
When women have reached the effective dose of their medication, it
is important to address the possible tapering/discontinuing plan of
the medication at that time. Generally, from the time the woman has
reached an effective dose of medication, discontinuation would be
considered 9 months to a year later. If this is a recurring
depression, the woman and her physician may discuss longer term
medication treatment.

Q. If I tell someone about my thoughts or symptoms,
won’t I be at risk for losing my baby? A. The
treatment goal is to promote and maintain a healthy mother-infant
relationship and bonding. Treatment interventions focus on reducing
the mother’s symptoms and increasing the mother’s support systems to
allow the mother to continue to care for her infant. In cases of
severe symptoms of impulses to harm self or the baby, interventions
would focus on the safety of both the mother and the infant until
those impulses have resolved. Losing custody of a child is a serious
issue that treatment professionals and society try to avoid. This is
extremely uncommon in women with postpartum depression. The illness is
treatable and rarely if ever results in the mother causing harm to her
infant. Sadly, Andrea Yates had postpartum psychosis (not depression)
and we hope that her terrible tragedy will bring more attention to
mothers in America, who have a high risk for psychiatric complications
of childbearing. 
Q. What is postpartum psychosis?
A. Postpartum psychosis is much less common and
affects 1-2 in 1000 women after having a baby. It typically presents
within 1 week and up to 4 weeks after delivery. This condition is
an emergency and women will require immediate clinical assessment
and treatment.
Symptoms progress quickly from irritability and problems falling
asleep, to symptoms of poor concentration, disorganized thinking,
unusual behaviors, unusual or irrational beliefs, agitation, and
rapid mood changes. They may express significant feelings of guilt
regarding her child or spouse. Women may experience major difficulties
caring for herself or others (children). Postpartum psychosis has
been linked with an increased risk of harming self or others. Postpartum
psychosis is most likely a manifestation of bipolar illness (manic
depressive illness). Women with this disorder should be preventively
treated in the postpartum period.

|